NCT00459719View on ClinicalTrials.gov

A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Liver Transplantation
Interventions
DRUG

Tacrolimus modified-release

oral

DRUG

Prograf

oral

Trial Locations (5)

Unknown

Beijing

Guangzhou

Shanghai

Hangzhou

Tianjin

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY